Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,635 | -37,381 | -115,252 | -84,350 | -55,064 |
| Depreciation Amortization | 1,350 | 525 | 1,528 | 1,062 | 722 |
| Accounts receivable | -1,857 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 5,486 | 2,890 | 979 | 1,142 | 1,338 |
| Other Working Capital | 1,832 | -1,404 | 3,788 | 113 | -218 |
| Other Operating Activity | 6,584 | 1,099 | 11,454 | 7,682 | 4,175 |
| Operating Cash Flow | $-56,240 | $-34,271 | $-97,503 | $-74,351 | $-49,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,061 | -1,814 | -3,438 | -1,622 | -462 |
| Investing Cash Flow | $-6,061 | $-1,814 | $-3,438 | $-1,622 | $-462 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 211,061 | 36,085 | 100,941 | 75,973 | 49,509 |
| Financing Cash Flow | $211,061 | $36,085 | $100,941 | $75,973 | $49,509 |
| Exchange Rate Effect | -4 | N/A | 0 | N/A | N/A |
| End Cash Position | 148,756 | N/A | 0 | N/A | N/A |
| Net Cash Flow | $148,756 | $N/A | $0 | $N/A | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -56,240 | -34,271 | -97,503 | -74,351 | -49,047 |
| Capital Expenditure | -6,061 | -1,814 | -3,438 | -1,622 | -462 |
| Free Cash Flow | -62,301 | -36,085 | -100,941 | -75,973 | -49,509 |